Slash Pharmaceutical
Slash Pharmaceutical is a domestic pharma company focused on GI and venous health. With seven products, including a venoactive therapy for HD and CVD, we deliver safe, effective, and evidence-based solutions in partnership with healthcare professionals.
At A Glance
Fastest-Growing Pharmaceutical Company
Slash Pharmaceutical is a rapidly expanding domestic pharmaceutical company focused on delivering high-quality gastrointestinal and venous health solutions. With a strong portfolio of seven innovative products, we are committed to improving patient outcomes through safe, effective, and evidence-based therapies.
Commitment of the CEO
Our commitment is to uphold the highest standards of quality, ethics, and innovation while continuously working to improve patient care. At Slash Pharmaceutical, we believe in building trust with healthcare professionals and delivering therapies that truly make a difference.
Mrs Amita Jain
CEO of Slash Pharmaceutical
Areas of Focus
Slash Pharmaceutical LLP specializes in developing high-quality treatments designed to improve patient quality of life through several key therapeutic categories:
Advanced Proctology & Topical Care: The portfolio features specialized topical treatments such as Anolash TRIO and Anolash Cream, which combine active ingredients like Sucralfate, Metronidazole, and Lidocaine to address localized pain and healing.
- Vascular & Venous Support: Through the Sliomin product line, the company provides Micronized Purified Flavonoid Fraction tablets in multiple strengths to support vascular health and manage chronic venous conditions.
- Neurological Wellness: The company supports nerve health with innovative delivery formats, such as Nervilash B6 mouth-dissolving tablets, which provide essential Vitamin B12, B6, and Folic Acid.
